Top Markets
#1 Derive Derive +31.47%
#2 Audiera Audiera +14.41%
#3 Palladium Network Palladium Network +12.66%
#4 The Bitcoin Bull The Bitcoin Bull +10.64%
#5 Cross Cross +10.45%
#6 Gama Token Gama Token +9.20%
#7 Geodnet Geodnet +8.35%
#8 Humanity Humanity +7.62%
#9 Cap Cap +7.48%
#10 Starpower Starpower +7.47%
Coin of the day
Derive Derive
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Telo Genomics Corp. Telo Genomics Corp.

Telo Genomics Corp.

TELO
Classificação em ações #35884
Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on... Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on creating and bringing to market advanced predictive solutions. Its core mission is to enable personalized treatment approaches for individuals suffering from specific health conditions. The company's primary innovation is a sophisticated telomere analysis platform, which serves both to diagnose diseases and to forecast patient outcomes. This technology, often integrated with liquid biopsies, provides crucial insights for applications in both cancer and neurological illnesses. Their leading product, Telo-MM, is specifically designed to arm medical professionals with vital, actionable information for effectively managing Multiple Myeloma, a serious blood cancer. Additionally, Telo Genomics offers TeloView, a proprietary software system capable of precisely measuring individual patient telomere characteristics. Telo Genomics caters to a broad spectrum of clients, including diagnostic pathologists, clinical doctors, academic researchers, and pharmaceutical developers. A notable endorsement of its technology is a collaborative agreement with the renowned Mayo Clinic, aimed at validating the Telo-MM diagnostic tests for multiple myeloma. Founded in 2014 and based in Toronto, Canada, the company adopted its current name, Telo Genomics Corp., in April 2019, having previously operated as 3D Signatures Inc.
Preço da ação
$0.03302716
Última sincronização: 2026-08-13
Valor de mercado
$3.32M
Variação (1 dia)
0.00%
Variação (1 ano)
-34.80%
País
CA
Negociar Telo Genomics Corp. (TELO)

Categoria

Healthcare
Lucros da Telo Genomics Corp. (TELO)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Telo Genomics Corp., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Telo Genomics Corp. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
$7.61B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
$4.76B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
$-252.70M -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
$1.42B -
US